COYA THERAPEUTICS, INC. COMMON STOCK

NASDAQ: COYA (Coya Therapeutics, Inc.)

Last update: 4 hours ago

5.08

-0.10 (-1.93%)

Previous Close 5.18
Volume 59,938
Price / Sales 13.15
Price / Book 2.87
52 Weeks Range
3.71 (-26%) — 7.75 (52%)
Operating Margin (TTM) -2,976.89%
Diluted EPS (TTM) -1.07
Quarterly Revenue Growth (YOY) 103.30%
Current Ratio (MRQ) 8.84
Operating Cash Flow (TTM) -15.26 M
Levered Free Cash Flow (TTM) -10.29 M
Return on Assets (TTM) -32.06%
Return on Equity (TTM) -52.11%

Market Trend

Short Term Medium Term
Industry Biotechnology (US) Mixed Bullish
Biotechnology (Global) Mixed Bullish
Stock Coya Therapeutics, Inc. Mixed Bearish

AIStockmoo Score

1.8
Analyst Consensus NA
Insider Activity NA
Price Volatility 1.0
Technical Moving Averages 2.5
Technical Oscillators 2.0
Average 1.83

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
COYA - - - 2.87
FENC - - - 8.68
FBLG - - - 2.00
AXSM - - - 121.64
PTGX - - - 10.67
ADMA - - - 5.32

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.

Sector Healthcare
Industry Biotechnology
Investment Style Small Growth
% Held by Insiders 7.02%
% Held by Institutions 28.08%

Ownership

Name Date Shares Held
Dme Capital Management, Lp 30 Jun 2026 2,335,540
Alyeska Investment Group, L.P. 30 Jun 2026 800,000
Cm Management, Llc 30 Jun 2026 400,000
Private Management Group Inc 30 Jun 2026 384,217
Prosight Management, Lp 30 Jun 2026 170,000
Jones Financial Companies Lllp 30 Jun 2026 110,910

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria